GLP-1 CVOT Evidence Synthesis Engine

Abstract

Extracting meta-analysis data from CG.gov represents a shift from static data visualization to active clinical decision support. Within our advanced  engine, data is processed through rigorous statistical guards. We use SUCRA scores to identify "Category Leaders,". The τ² thresholds trigger automated heterogeneity and by integrating Bayesian posterior probabilities with rule-based logic we classify molecules like Tirzepatide by their actual probability of superiority. This framework emulates target trials, by adjusting for population shifts identified in PCA geometry. This rules-based synthesis prevents the misinterpretation of noisy registry data with an "Executive Intelligence" text output that mirrors high-level health technology assessments. We take a pool of divergent trials converting them into a coherent evidence-based hierarchy for modern therapeutic guidelines.